Searched for
WHY MODERNA SHARES FELL
Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leakModerna’s stock price dropped over 25% after trial results for its personalized melanoma vaccine with Merck were disclosed. The decline era...- US stocks: US market rises as cooler inflation data ease October Fed hike betsU.S. stocks surged higher as inflation reports came in softer than analysts predicted, easing worries about potential interest rate hikes. ...
- Vivek Ramaswamy is worth $2.3bn. A win in Ohio could make him America’s second-richest governorVivek Ramaswamy's fortune has significantly increased due to Roivant Sciences' stock performance. He has sold billions in company stock ove...
- US stocks today: Nasdaq gains as Nvidia results revive confidence in AI tradeUS stocks rose on Thursday, led by the Nasdaq, as Nvidia's strong forecast eased concerns over slowing AI demand. Salesforce and CrowdStrik...
- US stocks today: US stocks end near flat as hot inflation data clouds Fed rate outlookWall Street ended nearly flat as hotter-than-expected US inflation complicated the Federal Reserve’s interest-rate outlook. Investors turne...
- US stocks today: US stocks close higher on tech rebound as Nvidia earnings gain focusUS stocks closed higher as technology and semiconductor shares recovered ahead of Nvidia's earnings. Lower oil prices and Treasury yields o...
- Memory stocks face headwinds as 'smart money' walks outMemory stocks showed initial promise but are now faltering, weighed down by anxiety surrounding the artificial intelligence market. Sandisk...
- US stocks: US market sinks as bond yields rise, Walmart results disappointThe S&P 500 consumer discretionary sector was one of the biggest drags on the benchmark index, with megacaps including Amazon and Tesla amo...
- US stocks: US market falls as bond yields rebound; Walmart slides on sales missMajor US stock indexes opened lower on Thursday. Rising government bond yields hurt investor sentiment significantly. Retail giant Walmart ...
- Global Market: China, Hong Kong stocks rebound as healthcare and tech shares rallyChina and Hong Kong stocks rebounded on Thursday, led by healthcare and technology shares, after a sharp selloff in the previous session. F...
- D-Street poised for a positive start as GIFT Nifty trades firmly higherNifty declined for a seventh session, influenced by elevated crude oil prices. Analysts anticipate continued pressure due to global weaknes...
- US stocks: US market rises as yields ease, Moderna lifts healthcare stocksUS stock markets enjoyed a boost as easing bond yields and a spike in Moderna shares contributed to a favorable trading environment. Despit...
- US stocks: US market regains ground as bond yields ease; healthcare stocks rallyMajor stock indexes recovered on Wednesday after a prior day's decline. Moderna shares surged significantly following positive cancer thera...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- AstraZeneca, BioNTech, GSK, Sanofi, Moderna, Novavax, Pfizer share prices: Why are vaccine stocks down?AstraZeneca, BioNTech, GSK, Sanofi, Moderna, Novavax, Pfizer stocks today remained muted.
- Share market update: Starbucks, Nucor, SoFi, and more - stocks that are moving the marketStocks have been making their moves recently, such as Starbucks, SoFi, Nucor, CSX, and more. Here are the details of them.
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Moderna lowers forecast for 2021 COVID-19 vaccine deliveriesThe drugmaker said Thursday that longer delivery lead times for exports and a temporary impact from expanding its fill-finish capacity may ...
- Moderna COVID-19 vaccine tallies more than $4 billion in Q2 salesModerna's announcement comes after pharmaceutical giant Pfizer Inc. said its COVID-19 vaccine remained effective months after the second do...
- European shares inch lower on doubts over Covid-19 vaccineThe pan-European STOXX 600 dropped 0.3 per cent by 0708 GMT in its second day of fall.
Load More
